Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0G0DZ
|
|||
Drug Name |
Prazosin
|
|||
Synonyms |
Furazosin; Prazosine; Prazosinum; Prazosina; Prazocin; Prazosinum [INN-Latin]; Prazosine [INN-French]; Prazosina [INN-Spanish]
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Coronavirus Disease 2019 (COVID-19) [ICD-11: 1D6Y] | Phase 2 | [1] | |
Therapeutic Class |
Antiviral Agents
|
|||
Structure |
Download2D MOL |
|||
Formula |
C19H21N5O4
|
|||
Canonical SMILES |
COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC
|
|||
InChI |
1S/C19H21N5O4/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14/h3-4,9-11H,5-8H2,1-2H3,(H2,20,21,22)
|
|||
InChIKey |
IENZQIKPVFGBNW-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 19216-56-9
|
|||
PubChem Compound ID | ||||
ChEBI ID |
CHEBI:8364
|
References | Top | |||
---|---|---|---|---|
REF 1 | Prazosin to Prevent COVID-19 (PREVENT-COVID Trial) (PREVENT) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.